Revenue Breakdown
Composition ()
No data
Revenue Streams
Stryker Corp (SYK) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medical, accounting for 16.3% of total sales, equivalent to $985.00M. Other significant revenue streams include Trauma and Extremities and Endoscopy. Understanding this composition is critical for investors evaluating how SYK navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Stryker Corp maintains a gross margin of 61.81%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 22.50%, while the net margin is 14.18%. These profitability ratios, combined with a Return on Equity (ROE) of 14.04%, provide a clear picture of how effectively SYK converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SYK competes directly with industry leaders such as BSX and MDT. With a market capitalization of $136.60B, it holds a significant position in the sector. When comparing efficiency, SYK's gross margin of 61.81% stands against BSX's 65.47% and MDT's 60.67%. Such benchmarking helps identify whether Stryker Corp is trading at a premium or discount relative to its financial performance.
